Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » CMS Reopens National Coverage Determination for NGS Testing in Advanced Cancer

CMS Reopens National Coverage Determination for NGS Testing in Advanced Cancer

May 01, 2019
|
staff reporter

NEW YORK (GenomeWeb) – The Centers for Medicare & Medicaid Services have officially reopened its national coverage determination for next-generation sequencing for advanced cancer patients in order seek public comments on germline testing. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

How Far the Butterfly Flies

Despite differences in their migration habits, eastern and western monarch butterflies are genetically similar, according to a study in Molecular Ecology.

Fast COVID-19 Testing for UK

The UK is implementing COVID-19 testing with a 90-minute turnaround time.

Teasing Out How Infections Spread

The Chan Zuckerberg Biohub is working with California's health department to sequence viral samples from COVID-19 patients to trace viral introductions, according to the San Francisco Chronicle.

PLOS Papers on Mycetoma Molecular Epidemiology, Campylobacter in Retail Meat, More

In PLOS this week: identification of fungal species in subcutaneous infections, sequencing of Campylobacter found in raw meat from retail stores, and more.

What's Popular?

In Reimbursement News

  1. Medicare to Cover Myriad Genetics' BRACAnalysis for FDA-Approved CDx Indications

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.